Concepedia

Carol A. Sargent

CA

Statistics

Publications

31

Citations

869

H-Index

20

Active since

1989

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Loughborough University

AstraZeneca (United Kingdom)

Carol A. Sargent is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, cardiology, and medicine.

Publications per year

1989–2011

31

Publications

31

Cardioprotective Profile of the Cardiac-Selective ATP-Sensitive Potassium Channel Opener BMS-180448

Gary J. Grover, John R. McCullough, Albert J. DʼAlonzo et al. · Journal of Cardiovascular Pharmacology · 1995 · 65 citations

Medicine, Cardiology, Pharmacology +17

Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages

Jane Armstrong, Carol A. Sargent, Dave Singh · Clinical & Experimental Immunology · 2009 · 65 citations · Full text

Medicine, Immunology, Inflammation +13

Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat

Katherine J. Escott, MG Belvisi, Mark A. Birrell et al. · British Journal of Pharmacology · 2000 · 57 citations · Full text

Life Sciences, Immunology, Pharmacology +14

The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.

G. J. Grover, Steven Dzwonczyk, Paul G. Sleph et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 55 citations

Medicine, Cardiology, Pharmacology +16

The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.

Carol A. Sargent, G. J. Grover, Michael J. Antonaccio et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 43 citations

Medicine, Cardiology, Pharmacology +17

1–5 of 31